24/7 Customer Support
doublle@doubllebio.com
DOUBLLE BIODOUBLLE BIO
  • Home
  • About
    • Corporate Honors
    • Team
  • Product
  • Service
    • Clinical Recruitment
  • News
  • Contact
  • CN
  • Home
  • About
    • Corporate Honors
    • Team
  • Product
  • Service
    • Clinical Recruitment
  • News
  • Contact
  • CN
+86 020 32053707
+86 020 32053707
Home Doublle › Clinical progress
2026年3月20日

[Patient Recruitment] Clinical Recruitment for Stem Cell Treatment of Type 2 Diabetes

Clinical progress No Comments 235 Views
Phase I clinical study on the safety, tolerability, and preliminary efficacy of E10I stem cell therapy for type 2 diabetes

About Us

The company was founded by Professor Huang Wenlin in 2001, and has been dedicated to the development and transformation of gene engineering technology applications, such as tumor-targeted drug gene therapy and cell therapy.

Our Contact Details

8th Floor, Building B1, Guangzhou Technology Business Accelerator

+86 020 32053707

doublle@doubllebio.com

QR code to contact

Copyright © GuangZhou Doublle Bio | All rights reserved.